IsoPlexis is building solutions to accelerate the development of curative medicines and personalized therapeutics.
ISO
0.741 as of 3/17/23
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/7/2021 | Series D | $92.5MM raised | $XXX.XX | $XXX.XX |
| 1/9/2020 | Series C and C-2 | $50MM raised | $XXX.XX | $XXX.XX |
| 9/26/2017 | Series B and B-2 | $13.68MM raised | $XXX.XX | $XXX.XX |
| 5/28/2015 | Series A-2 | $3.69MM raised | $XXX.XX | $XXX.XX |
| 7/6/2014 | Series A | $1.65MM raised | $XXX.XX | $XXX.XX |
